Fagron Compounding Services Recalls

Fagron Compounding Services Vancomycin HCl 1 g in 250 mL NS Injection Recall Expands in 2026

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Fagron Compounding Services Vancomycin HCI Recall: 34,260 Bags with Break-Off-Part Risk (2026)

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Fagron Compounding Services Norepinephrine Bitartrate Injection Recall Affects 5,140 Bags (2026)

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Fagron Compounding Services Recalls Ophthalmic Solution Over Incorrect Formulation

Fagron Compounding Services Bevacizumab Syringe Recall Affects 109,320 Units Nationwide

Lack of Assurance of Sterility